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Fig 2. Right subclavian vein PTA (a) and stenting (b and c).
Fig 3. Stent fracture and severe subclavian vein stenosis
Fig 4. Stent fracture (blue arrow) at the junction of the immobile and
mobile (black arrows) part of the stent. The red and green lines represent the
centre line of the stent in the lower and the upper position. We note that the
lateral half of the stent is practically not moving while the medial part
demonstrates substantial mobility. The mobility of this fractured stent is
simply an indirect witness for the movements of the subclavian vein. PTA,
Percutaneous transluminal angioplasty
Fig 1. Chest X-ray post ﬁrst rib resection (arrow)
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Volume 58, Number 5 Abstracts 1441immobile part of the stent (Fig 4). A new balloon-expandable covered
stent was implanted. During this procedure, two interesting observations
were made: 1) Rotational forces induced a medial and downward motion
with inspiration; and 2) The new intact stent was resistant to these forces
which, however, over time, may be overcome and lead to recurrent
fracture.
Discussion: The increase in interventional treatment for TOS has
been associated with stenting of the subclavian vein following osseous
decompression. In our patient, the repetitive strain on the nitinol stent skel-
eton, created by the moving medial portion of the subclavian vein, may have
signiﬁcantly contributed to stent fracture. Based upon video imaging, it
appears that the lateral part of the subclavian vein moves upward during
inspiration while the proximal medial segment follows the motion of the
mediastinum and moves downwards, leading to an area of repeated ﬂexion
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Objectives: Cryopreserved grafts are increasingly utilized for vascular
reconstruction, particularly in the setting of infection. There are known limi-
tations associated with their use, including graft degeneration with
aneurysm formation. We review our experience with endovascular manage-
ment of delayed complications of cryopreserved bypass grafts.
Methods and Results: Chart review of ﬁve patients who had endo-
vascular repair of cryopreserved bypass graft complications was performed.
Data including indication for surgery, indication for cryopreserved conduit,
complication, time to complication, intervention, and follow-up were ob-
tained. Results are as described in the Table.
Conclusions: Cryopreserved bypass grafts are prone to degeneration
with aneurysm formation. Endovascular therapy provides an initial manage-
ment strategy, however data question their durability as a deﬁnitive
intervention.
